Magma Fincorp (Q2 FY16): ‘Pressure on Asset Quality persists’ – BUY
|
Click here for the detailed report on the same. |
Cipla (Q2 FY16): gNexium moderation sets in – Accumulate
|
Click here for the detailed report on the same. |
Tata Steel Ltd (Q2 FY16): Earnings under pressure – Reduce
|
Click here for the detailed report on the same. |
JK Lakshmi Cements Ltd (Q2 FY16): Lower margin drags PAT into negative – BUY
|
Click here for the detailed report on the same. |
IPCA Laboratories (Q2 FY16): Another muted quarter – SELL
|
Click here for the detailed report on the same. |
Greaves Cotton (Q2 FY16): Strong margin performance continues – BUY
|
Click here for the detailed report on the same. |
IOC (Q2 FY16): Inventory losses hurt GRMs – Buy
|
Click here for the detailed report on the same. |
Power Grid (Q2 FY16): Earnings growth to accelerate – BUY
|
Click here for the detailed report on the same. |
GAIL (India) Ltd (Q2 FY16): Weak operational performance – SELL
|
Click here for the detailed report on the same. |
Granules India (Q2 FY16): Strong performance continues – Accumulate
|
Click here for the detailed report on the same. |
Cox & Kings (Q2 FY16): Steady performance – Accumulate
|
Click here for the detailed report on the same. |
United Spirits (Q2 FY16): Robust margin performance – Accumulate
|
Click here for the detailed report on the same. |
Cipla (Q2 FY16): gNexium moderation sets in – Accumulate
CMP Rs659, Target Rs700, Upside 6.1%
When SB account gives guaranteed, risk-free 6% returns for 12 months, why we need to buy CIPLA for not guaranteed returns of 6.1% with the risk of losing capital ?